Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced that its first results from the ongoing inMMyCAR study, a Phase 1 clinical trial ...
In a recent study published in the journal PLOS Pathogens, researchers from the United States of America (US) investigated the resistance profile of 4’-fluorouridine (4’-FlU) against an avian ...
TEL AVIV, Israel and BETHESDA, Maryland, Feb. 3, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicines, ...
Independent in vivo study demonstrates up to 85% survival in a viral inflammatory mouse model treated with Argent’s ArtemiC ArtemiC is a US over the counter brand of CimetrA – a nano-formulated oral ...
Amid the Coronavirus pandemic, the average users have apparently become more fixated towards their smartphone. A new study from Vivo and Cyber Media Research has revealed that the increased usage of ...
MUNICH--(BUSINESS WIRE)--After completing a 60-day pre-clinical study, Professor Stephen Wildhirt, MD, PhD, CEO at AdjuCor, is excited to report on its success. Apart from other achievements, the ...
Alzheimer's disease (AD) is the most common form of dementia with nearly 44 million people affected worldwide. Characteristic neuropathological hallmarks of the disease are β-amyloid plaques which ...
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug ...
Randomized, Multicenter Trial of Fluorouracil Plus Leucovorin Administered Either Via Hepatic Arterial or Intravenous Infusion Versus Fluorodeoxyuridine Administered Via Hepatic Arterial Infusion in ...
Scientists have engineered a nanowire platform that mimics brain tissue to study astrocytes, the star-shaped cells critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback